Skip to content

A clinical study of digital-assisted design bone plates for alveolar bone defect reconstruction

A clinical study of digital-assisted design bone plates for alveolar bone defect reconstruction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121870
Enrollment
Unknown
Registered
2026-04-07
Start date
2026-04-07
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dentition Defect

Interventions

Concurrent group:Bone augmentation using digital-assisted design bone plate with simultaneous implant placement.
Non-concurrent group:Bone augmentation using digital-assisted design bone plate without simultaneous implant placement.

Sponsors

West China Hospital of Stomatology, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Missing teeth or teeth indicated for extraction , complicated by horizontal alveolar bone defects. 2.The participant is in good health and can tolerate the operation. 3.Participants fully understand the benefits and risks of this trial, and are willing to participate and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Heart diseases (including grade II and above heart function disorders); abnormal liver and kidney functions (ALT, AST > 1.5 times the normal value; patients with diabetes, those whose blood sugar levels are poorly controlled (even after controlling fasting blood sugar, it is still >= 8.0 mmol/L)); 2. Patients with uncontrolled oral diseases, such as progressive periodontal disease, severe periapical infection, and severe habitual bruxism patients; 3. New metabolic diseases that are not under control, such as diabetes, osteomalacia, thyroid diseases, and severe liver and kidney dysfunction; 4. Patients with bone diseases such as osteoporosis, osteomalacia, and osteosclerosis; 5. Malignant tumors, active infectious lesions, and various bone defects caused by active metabolic bone diseases; 6. Patients with systemic infections or acute infections at the surgical site; 7. Blood diseases such as aplastic anemia, and those who have taken anticoagulant drugs in the past 3 months or whose coagulation tests are not within the normal range; 8. Patients who use drugs that may affect the healing of soft and hard tissues, such as long-term use of sedative-hypnotic drugs (continuous use for more than 3 months), long-term use of non-steroidal anti-inflammatory drugs or adrenal cortical hormones (continuous use for more than 3 months), and those who have received drug treatment that may affect or promote bone metabolism in the past 3 months or within the last 3 months; 9. Patients with severe smoking habits (smoking more than 20 cigarettes per day) within the past 6 months and during the bone healing period; 10. Autoimmune diseases; 11. Undergoing radiotherapy; 12. Mental disorders, drug abuse, alcoholism; 13. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Bone width;

Secondary

MeasureTime frame
Wound Healing;Postoperative pain;Operating time;

Countries

China

Contacts

Public ContactMo Anchun

West China Hospital of Stomatology, Sichuan University

moanchun@163.com+86 28 8550 4389

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026